LETTER TO THE JOURNAL
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer
Stefano Volinia, Anna Terrazzan, Tomasz S. Kaminski, Krystian Jadzewski, Eva Reali, Nicoletta Bianchi, Jeff Palatini
Cancer Communications 2025 45: [Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/23/2025 doi:10.1002/cac2.12664
LETTER TO THE JOURNAL
Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma
Jia Xiang Jin, Fabia Fuchslocher, Martha Carreno-Gonzalez, Felina Zahnow, A. Katharina Ceranski, Rainer Will, Dominic Helm, Felix Bestvater, Ana Banito, Roland Imle, Shunya Ohmura, Florencia Cidre-Aranaz, Thomas G. P. Grünewald
Cancer Communications 2025 45: [Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/20/2025 doi:10.1002/cac2.12665
ORIGINAL ARTICLE
Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial
Jianli Ma, Jingxuan Wang, Ting Xu, Quchang Ouyang, Xiaojia Wang, Jingfen Wang, Lu Gan, Zhong Ouyang, Daren Lin, Tao Sun, Changping Shan, Herui Yao, Baochun Zhang, Zhengguang Li, Zhixiang Zhuang, Ying Lu, Hongwei Yang, Jian Huang, Xingwang Yang, Hongmei Sun, Qingyuan Zhang
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/18/2025 doi:10.1002/cac2.12662
LETTER TO THE JOURNAL
Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors
Hye Jung Baek, Geun Hee Han, Eun Joo Cho, Jihao Xu, Min Kyung Ki, Eun Jung Park, Tae Hyun Kim, Dong Hoon Shin, Heesun Cheong, Chu-Xia Deng, Sung Chul Lim, Chang-il Hwang, Daehee Hwang, Sang Soo Kim
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/18/2025 doi:10.1002/cac2.12663
LETTER TO THE JOURNAL
Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives
Ruben Malmberg, Bram C. Agema, Maaike M. Hofman, Stefani Oosterveld, Sander Bins, Daphne W. Dumoulin, Arjen Joosse, Joachim G. J. V. Aerts, Reno Debets, Birgit C. P. Koch, Astrid A. M. van der Veldt, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/16/2025 doi:10.1002/cac2.12661
LETTER TO THE JOURNAL
Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity
Antonia Stubenvoll, Maria Schmidt, Johanna Moeller, Max Alexander Lingner Chango, Carolyn Schultz, Olga Antoniadou, Henry Loeffler-Wirth, Stephan Bernhart, Florian Gro?e, Beatrice Thier, Annette Paschen, Ulf Anderegg, Jan C. Simon, Mirjana Ziemer, Clara T. Schoeder, Hans Binder, Manfred Kunz
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/15/2025 doi:10.1002/cac2.12651
LETTER TO THE JOURNAL
Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy
Charles Pottier, Laetitia Montero-Ruiz, Robin Jehay, Coline Wery, Dominique Baiwir, Gabriel Mazzucchelli, Sophie Bekisz, Romain Thissen, Claire Josse, Andrée Rorive, Stéphanie Gofflot, Ahmed Dahmani, Ludivine Morisset, Jo?lle Collignon, Philipe Delvenne, Elisabetta Marangoni, Agnès No?l, Guy Jerusalem, Nor Eddine Sounni
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/13/2025 doi:10.1002/cac2.12646
LETTER TO THE JOURNAL
To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?
Fatemeh Safizadeh, Marko Mandic, Michael Hoffmeister, Hermann Brenner
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/10/2025 doi:10.1002/cac2.12659
ORIGINAL ARTICLE
Efficacy and safety of first-line sintilimab plus anlotinib versus chemotherapy for metastatic non-small cell lung cancer: a phase II, open-label, randomized controlled trial
Tianqing Chu, Hua Zhong, Zhuang Yu, Jing Wang, Yanqiu Zhao, Xiaoqian Mu, Xinmin Yu, Xun Shi, Qingming Shi, Maojing Guan, Cuimin Ding, Nan Geng, Jialin Qian, Baohui Han
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/10/2025 doi:10.1002/cac2.12654
RESEARCH HIGHLIGHTS
Training the synergy between Bacillus Calmette-Guérin and immune checkpoint-blocking antibodies in bladder cancer
Renate Pichler, Martin Thurnher
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/10/2025 doi:10.1002/cac2.12647
